Skip to main content
Atrás
Watch Compare

CANNAPHARMARX, INC.

Calidad de datos: 100%
CPMD
OTC Manufacturing Chemicals
$0.00
$0.00 (0.00%)
6 months return
—
Momentum
Neutral
Net margin
-817.19%

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)66.09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
N/A
ROICN/A
Net Margin-817.19%
Op. Margin-245.77%

Seguridad

Debt / Equity
N/A
Current Ratio0.05
Interest Coverage-1.71

Valoración

PE (TTM)
-0.24
Above sector avg (-1.50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -794,621.0
Capital efficient — spends only 0.41% of revenue on capex

Price History

Tendencias Financieras

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) 66.09% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: N/A · Net Margin: -817.19%
Revenue (TTM) 1.36 M Net Income (TTM) -11.13 M
ROE N/A ROA -96.42%
Gross Margin -153.06% Operating Margin -245.77%
Net Margin -817.19% Free Cash Flow (TTM) -794,621.0
ROIC N/A FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.05
Debt / Equity N/A Current Ratio 0.05
Interest Coverage -1.71 Asset Turnover 0.12
Working Capital -27.01 M Tangible Book Value -22.52 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.24 · EV/EBITDA: N/A
P/E Ratio -0.24 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1.99
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -29.28%
Market Cap 2.71 M Enterprise Value 2.71 M

Per Share

EPS: -0.02 · FCF/Share: 0.00
EPS (Diluted TTM) -0.02 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 7.14% · CapEx/Rev: 0.41%
CapEx / Revenue 0.41% FCF Conversion 7.14%
SBC-Adj. FCF -794,621 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Revenue 1.36 M 820,137.0 0.0 0.0 0.0
Net Income -11.13 M -9.91 M -8.53 M -8.83 M -19.89 M
EPS (Diluted) -0.02 -0.02 0.04 — —
Gross Profit -2.08 M -2.93 M — — —
Operating Income -3.35 M -3.61 M -5.21 M -2.99 M -14.49 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — 116,640.0 — — —
D&A — 0.0 294,934.0 2,708.0 128,505.0
Interest Expense 1.96 M 2.26 M 2.29 M 1.51 M 2.29 M
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2022 FY2021 FY2020
Total Assets 7.02 M 10.84 M 5.41 M 114,330.0 8.75 M
Total Liabilities 37.17 M 30.65 M 22.76 M 13.04 M 17.55 M
Shareholders' Equity -30.15 M -19.81 M -17.34 M -12.93 M -8.80 M
Total Debt — — — — —
Cash & Equivalents 1,804.0 2,156.0 2,317.0 27,767.0 334,969.0
Current Assets 1.31 M 1.02 M 100,014.0 29,538.0 467,551.0
Current Liabilities 31.59 M 25.75 M 17.17 M 13.04 M 17.55 M

Comparación con Pares

vs mediana del sector Manufacturing (1605 pares)
Métrica Acción Mediana del Sector
P/E -0.2 -1.5
P/B — 1.6
ROE % — -54.5
Net Margin % -817.2 -41.5
Rev Growth 5Y % — 1.7
D/E — 0.3